COAGULATION FACTOR XII - ANVISA Registration 10287411639
Access comprehensive regulatory information for COAGULATION FACTOR XII in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411639 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including TCOAG IRELAND LIMITED, DIAGNOSTICA STAGO S.A.S., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10287411639
25351356359202201
30280358000186
Company Information
Dates and Status
Oct 13, 2022
VIGENTE
09/18/2025 19:00:01
COAGULATION FACTOR XII
TrinCLOT Factor XII
TCOAG IRELAND LIMITED
81457600021
Feb 03, 2020
COAGULATION FACTOR XII
STA – Immunodef XII
DIAGNOSTICA STAGO S.A.S.
80102511026
Jan 31, 2012
COAGULATION FACTOR XI
Factor FXI
ROCHE DIAGNOSTICS GMBH
10287411637
Oct 13, 2022
COAGULATION FACTOR II
Factor II
ROCHE DIAGNOSTICS GMBH
10287411538
Oct 15, 2020
COAGULATION FACTOR XIII
Factor FXIII
ROCHE DIAGNOSTICS GMBH
10287411641
Oct 20, 2022